1 citations
,
August 2022 in “Медицинский совет” This study reported that among patients aged 19 to 60 who experienced hair loss after COVID-19, a treatment involving a complex drug and peptide lotion led to hair improvement in 92% of cases, with good tolerability and no reported side effects.
8 citations
,
March 2022 in “Journal of Cosmetic Dermatology” This study concluded that mesotherapy appears effective for treating pattern hair loss, but emphasizes a need for more research comparing it to other treatments due to limited sample sizes.
25 citations
,
February 2022 in “JAAD International” This review analyzed data on alopecia types associated with COVID-19, suggesting androgenetic alopecia may be a risk factor for severe COVID-19, while telogen effluvium often follows infection and alopecia areata tends to relapse in those with preexisting disease.
8 citations
,
October 2021 in “Indian Journal of Plastic Surgery” This review discusses potential pathways leading to hair loss after infection and suggests that COVID-19 may cause a shorter latency period for hair fall compared to other infections, though it reports no new clinical results.
1 citations
,
August 2021 in “Arhivʺ vnutrennej mediciny” This review discusses the role of hormones and other factors in the development of alopecia linked to endocrine disorders, but reports no new clinical results, emphasizing the need for a multidisciplinary diagnostic approach.
1 citations
,
January 2021 in “Journal of Cutaneous and Aesthetic Surgery” This review indicates that low-level laser therapy may stimulate hair growth in both men and women with androgenetic alopecia, showing similar efficacy to minoxidil in some studies, but requires more robust evidence.
1 citations
,
December 2020 in “Medicinskij alfavit” This review discusses current understandings and treatments of telogen effluvium, including hardware lighting technologies for hair loss, but presents no new clinical results.
27 citations
,
December 2020 in “Experimental Dermatology” This study reported that COVID-19 was causally associated with postinfectious hair shedding, which varied with disease severity, but hair completely recovered.
121 citations
,
November 2020 in “Endocrine” This review discusses evidence on androgen sensitivity as a potential factor in COVID-19 disease severity, suggesting that androgen receptor interactions could influence virus entry and progression, and reports no new clinical results.
24 citations
,
August 2020 in “AJGP” A woman's sudden hair loss was linked to her previous COVID-19 infection.
119 citations
,
May 2020 in “Journal of The American Academy of Dermatology” This study observed a high prevalence of androgenetic alopecia in patients hospitalized with severe COVID-19, with 79% of men and 42% of women affected, suggesting a potential link between androgen sensitivity and COVID-19 severity.
11 citations
,
February 2020 in “Dermatology and therapy” This study reported that four patients with lichen planopilaris showed dramatic improvement, including symptom reduction and hair regrowth, after treatment with low-level light therapy.
8 citations
,
August 2019 in “Dermatologic surgery” This review covers nonsteroid-based therapies for alopecia areata, finding potential in PRP, UVR, and laser treatments, but highlights a lack of high-quality evidence for their efficacy.
1 citations
,
January 2019 in “Journal of Research in Medical Sciences” This study found that a lower number of GGC sequences in the androgen receptor gene was associated with better clinical response to finasteride in male androgenetic alopecia patients.
41 citations
,
December 2017 in “Lasers in Medical Science” This study found that low-level laser therapy may significantly improve androgenic alopecia in both men and women, either alone or alongside treatments like minoxidil and finasteride.
58 citations
,
December 2017 in “Journal of The European Academy of Dermatology and Venereology” This review highlights that microneedling shows some promise for improving hair growth in alopecia, particularly when used with other treatments, though more research is needed to establish its efficacy and protocols.
145 citations
,
November 2017 in “Journal of The European Academy of Dermatology and Venereology” This guideline review by the European Dermatology Forum evaluates current treatments for androgenetic alopecia but reports no new research findings, aiming to assist dermatologists in selecting safe and effective therapies.
178 citations
,
April 2017 in “Journal of The American Academy of Dermatology” This systematic review and meta-analysis found that minoxidil, finasteride, and low-level laser light therapy significantly improve hair growth in men with androgenetic alopecia, while minoxidil is also effective for women, compared to placebo.
4 citations
,
June 2016 in “Rossiiskii Zhurnal Kozhnykh i Venericheskikh Boleznei” This study describes a clinical investigation of telogen effluvium with iron deficiency anemia, comparing treatment with Fe2+ salts alone to Fe2+ salts plus topical Qilib, but reports no new results.
165 citations
,
August 2013 in “Lasers in Surgery and Medicine” This review discusses the potential mechanisms and evidence supporting low-level laser therapy for stimulating hair growth in men and women, while noting its safety and effectiveness but needing further study on specific parameters.
151 citations
,
August 2010 in “British Journal of Dermatology” This guideline reviews the diagnosis of androgenetic alopecia and offers expert consensus recommendations tailored to males, females, and adolescents, but reports no new clinical results.